“I hope Sputnik V has the same chances of approval as other vaccines.
This will allow maintaining real competition for vaccines in Europe, ”she told RIA Novosti.
According to the agency, representatives of the AfD delegation met with the developers of Sputnik V and representatives of the RDIF and discussed vaccination in Russia and the EU.
On March 4, it became known that the European Medicines Agency has begun a procedure for the consistent examination of the registration dossier of Sputnik V.
As stated in the department, the regulator intends to check the compliance of the drug with EU standards, any decision of the department will be based solely on scientific data.